Tradjenta is a Oral Tablet, Film Coated in the Human Prescription Drug category. It is labeled and distributed by A-s Medication Solutions. The primary component is Linagliptin.
Product ID | 50090-4383_5e9e8353-ce09-4675-b171-300d9019fda8 |
NDC | 50090-4383 |
Product Type | Human Prescription Drug |
Proprietary Name | Tradjenta |
Generic Name | Linagliptin |
Dosage Form | Tablet, Film Coated |
Route of Administration | ORAL |
Marketing Start Date | 2011-05-09 |
Marketing Category | NDA / NDA |
Application Number | NDA201280 |
Labeler Name | A-S Medication Solutions |
Substance Name | LINAGLIPTIN |
Active Ingredient Strength | 5 mg/1 |
Pharm Classes | Dipeptidyl Peptidase 4 Inhibitors [MoA],Dipeptidyl Peptidase 4 Inhibitor [EPC] |
NDC Exclude Flag | N |
Listing Certified Through | 2020-12-31 |
Marketing Start Date | 2019-06-24 |
NDC Exclude Flag | N |
Sample Package? | N |
Marketing Category | NDA |
Application Number | NDA201280 |
Product Type | HUMAN PRESCRIPTION DRUG |
Marketing Start Date | 2019-06-24 |
Ingredient | Strength |
---|---|
LINAGLIPTIN | 5 mg/1 |
SPL SET ID: | b1da67d4-51e0-41b7-9fe1-7f38c0d1baa1 |
Manufacturer | |
UNII | |
RxNorm Concept Unique ID - RxCUI |
NDC | Brand Name | Generic Name |
---|---|---|
0597-0140 | Tradjenta | linagliptin |
50090-4383 | Tradjenta | linagliptin |
55154-0410 | Tradjenta | linagliptin |
Mark Image Registration | Serial | Company Trademark Application Date |
---|---|
TRADJENTA 85223216 4103139 Live/Registered |
Boehringer Ingelheim International GmbH 2011-01-21 |